Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















пересадка стволовых клеток при онкологии

The data of the first intermediate analysis of results of research BCRIG01 are published, in which comparison of efficiency of standard mode FAC (500/50/500) with a таксан-containing mode (with inclusion Таксотера) ТАС (75/50/500 (1) is lead{carried out}. Both modes were used with an interval of 3 weeks in quantity{amount} of 6 rates. This first published research estimating a role доцетаксела (Таксотера) in адъювантной of therapy of a cancer dairy железы. Earlier in two other researches (С9344 and В30) the role паклитаксела has been investigated, and one of them (С9344) has shown increase безрецидивной and the general{common} survival rate at patients with рецептороотрицательными tumours at use паклитаксела is consecutive with a mode the EXPERT. Подробнее...

Braverman with соавт. (5) have estimated a hormonal background at 16 women (middle age 43 years) with come{stepped} owing to chemotherapy аменореей in from 3 till 44 months (a median - 8,5 months). The level сывороточного эстрадиола at 60 % of patients corresponded{met} пременопаузальному in spite of the fact that the level фолликулостимулирующего hormone (ФСГ) was in постменопаузальном a range. The received data are necessary for considering at purpose{assignment} ингибиторов ароматазы to women with induced chemotherapy аменореей. It is obvious, that at this category of patients менопаузальный it is necessary to confirm the status definition of a level эстрадиола and ФСГ which further should be supervised each 3 months. Подробнее...